Cancer drug Imfinzi improves survival chances in late-stage trial
LONDON - Lung cancer patients treated with AstraZeneca's immunotherapy Imfinzi pre- and post-surgery in a trial lived significantly longer without ...
LONDON - Lung cancer patients treated with AstraZeneca's immunotherapy Imfinzi pre- and post-surgery in a trial lived significantly longer without ...
Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.
Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.